Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals. However, symptoms returned in some patients after treatment was completed, prompting the Centers for Disease Control and Prevention (CDC) to issue a health advisory on this so-called...
Paxlovid rebound patient did not show drug resistance or impaired immunity; UC San Diego study suggests insufficient drug exposure was most likely cause
Stem cell researcher Jan Nolta received the Lifetime Achievement Award in Innovation during the 2022 Chancellor’s Innovation Awards ceremony on June 16. The awards recognize faculty, community partners and industry leaders developing innovative solutions to improve the lives of others and address important needs in the global society.
Specialty Pharmacy was honored for high patient-satisfaction ratings by the National Association of Specialty Pharmacy, which conducts patient-satisfaction studies for specialty pharmacies around the country.
Mass shooters frequently share their plans, creating opportunities to intervene. Experts from the UC Davis Violence Prevention Research Program provide an overview of the research on mass shootings and the “red flag” laws or extreme risk protection orders (ERPOs) designed to stop them.
Researchers at University of California San Diego School of Medicine are conducting a longitudinal study to track neurological symptoms in COVID-19 “long-haulers.” The first round of results, published June 15, 2022 in Annals of Clinical and Translational Neurology, revealed the...
Health Media Contacts
Find the best contact for health-related media inquiries.
